deltatrials
Active Not Recruiting OBSERVATIONAL NCT03614689

Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire

Sponsor: Geneplus-Beijing Co. Ltd.

Conditions Ovarian Cancer
Updated 9 times since 2018 Last updated: Jul 16, 2024 Started: Nov 25, 2017 Primary completion: Nov 30, 2020 Completion: Dec 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Ovarian Cancer, this trial is ongoing. The trial is conducted by Geneplus-Beijing Co. Ltd. and has accumulated 9 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Sep 2018 – ~Dec 2020 · 27 months · monthly snapshotRecruiting~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotUnknown Status~Jan 2021 – ~Apr 2022 · 15 months · monthly snapshotUnknown Status~Apr 2022 – ~Jun 2023 · 14 months · monthly snapshotActive Not Recruiting~Jun 2023 – ~Mar 2024 · 9 months · monthly snapshotActive Not Recruiting~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshotActive Not Recruiting~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshotActive Not Recruiting~Sep 2024 – present · 22 months · monthly snapshotActive Not Recruiting

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Active Not Recruiting

  2. Aug 2024 — Sep 2024 [monthly]

    Active Not Recruiting

  3. Jul 2024 — Aug 2024 [monthly]

    Active Not Recruiting

  4. Mar 2024 — Jul 2024 [monthly]

    Active Not Recruiting

  5. Jun 2023 — Mar 2024 [monthly]

    Active Not Recruiting

▶ Show 4 earlier versions

  1. Apr 2022 — Jun 2023 [monthly]

    Active Not Recruiting

    Status: Unknown Status → Active Not Recruiting

  2. Jan 2021 — Apr 2022 [monthly]

    Unknown Status

  3. Dec 2020 — Jan 2021 [monthly]

    Unknown Status

    Status: Recruiting → Unknown Status

  4. Sep 2018 — Dec 2020 [monthly]

    Recruiting

    First recorded

Nov 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Geneplus-Beijing Co. Ltd.
  • Peking Union Medical College Hospital
Data source: Geneplus-Beijing Co. Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations